$3.85 -$0.03 (-0.8%)

04:00 PM EST on 11/12/19

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)

CAPS Rating: 1 out of 5

Current Price $3.85 Mkt Cap $87.7M
Open $3.88 P/E Ratio 0.00
Prev. Close $3.88 Div. (Yield) $0.00 (0.0%)
Daily Range $3.76 - $3.88 Volume 29,694
52-Wk Range $3.31 - $4.50 Avg. Daily Vol. 43,458

Caps

How do you think NASDAQ:BCLI will perform against the market?

Add Stock to CAPS Watchlist

All Players

17 Outperform
17 Underperform
 

All-Star Players

3 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BCLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

slcrocker (49.03)
Submitted January 02, 2015

An amazing little company that is getting the recognition it deserves. ALS treatment, up list and company showing promise.

jed71 (99.87)
Submitted November 07, 2014

Easy, Peasey call. Another kitschy company name…. Brainstorm? How cute. “On September 15, 2014, Brainstorm Cell Therapeutics Inc. (the “Company”) filed a Certificate of Amendment of Certificate of Incorporation (the “Certificate of Amendment”) with… More

NASDAQ:BCLI VS S&P 500 (SPY)

NASDAQ:BCLI Summary

Fools bullish on NASDAQ:BCLI are also bullish on:

Fools bearish on NASDAQ:BCLI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BCLI.

Recs

0
Member Avatar TerryHogan (99.97) Submitted: 12/4/2018 1:09:30 AM : Underperform Start Price: $3.11 NASDAQ:BCLI Score: -12.79

Well first of all, I like to bet against companies based solely on the silliness of their names - it worked awesome when shorting this weird company named goo goo gaa gaa or something.... oh yeah, "Google" that's it. But anyways, beyond that, this company has zero revenue in 4 years, with inconsistent spending on R & D. At least if it was continually burning big cash on R & D you might think there was something huge in the pipe. I have serious 'going concern' concerns about this company.

Recs

0
Member Avatar manirg (< 20) Submitted: 8/19/2015 10:17:03 PM : Outperform Start Price: $2.91 NASDAQ:BCLI Score: -23.40

Insider buying

Recs

0
Member Avatar biotechf (95.24) Submitted: 4/14/2015 11:58:54 AM : Outperform Start Price: $4.93 NASDAQ:BCLI Score: -69.67

A trade on the presentation the morning of Tuesday, April 21, during the American Academy of Neurology annual meeting in Washington, D.C.

Leaderboard

Find the members with the highest scoring picks in BCLI.

Score Leader

kdakota630

kdakota630 (30.37) Score: +99.24

Yay! How long have I been score leader here? Something tells me it won't last long, but I'll enjoy it while I can.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
saab93boi < 20 1/2/2015 Underperform 5Y $7.16 -46.23% +50.81% +97.04 0 Comment
ProdigalSun < 20 1/5/2015 Underperform NS $6.68 -42.37% +51.34% +93.71 0 Comment
FoolTheRest 99.95 11/10/2014 Underperform 5Y $3.65 +5.48% +51.93% +46.45 0 Comment
jed71 99.87 11/6/2014 10/11/2019 Underperform 5Y $3.55 +8.45% +52.10% +43.65 2 Comments
XMFYoung 99.95 11/14/2014 Underperform 1Y $3.51 +9.69% +51.25% +41.56 0 Comment
onthewallst 99.92 11/18/2014 Underperform 5Y $3.35 +14.93% +51.14% +36.22 0 Comment
beecha < 20 8/29/2017 Underperform 5Y $4.15 -7.23% +27.13% +34.36 0 Comment
MMCapitalMgmt 99.92 11/26/2014 Underperform 5Y $3.29 +17.02% +49.07% +32.05 0 Comment
zzlangerhans 99.80 7/15/2016 Underperform 1Y $3.07 +25.41% +43.29% +17.88 0 Comment
EvanBuck 99.92 12/11/2014 Underperform 5Y $2.88 +33.68% +50.00% +16.32 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BCLI.